Psychedelics are psychiatryâs new hope Once-demonised hallucinogens such as psilocybin are showing astonishing promise in the treatment of post-traumatic stress disorder. Psilocybin is the psychedelic found in âmagic mushroomsâ such as psilocybe semilanceata. Andrew Jacobs Save Share Itâs been a long, strange trip in the four decades since Rick Doblin, a pioneering psychedelics researcher, dropped his first hit of acid in college and decided to dedicate his life to the healing powers of mind-altering compounds. Even as anti-drug campaigns led to the criminalisation of ecstasy, LSD and magic mushrooms, and drove most researchers from the field, Doblin continued his quixotic crusade with financial help from his parents.
The psychedelic revolution is coming. Psychiatry may never be the same By Andrew Jacobs New York Times,Updated May 9, 2021, 9:24 p.m. Email to a Friend Rick Doblin, director of the Multidisciplinary Association for Psychedelic Studies, a nonprofit research group, at his home in Belmont, Mass. on April 9, 2021. A new study shows that MDMA, the illegal drug known as Ecstasy or Molly, can bring relief when paired with talk therapy to those with severe post-traumatic stress disorder.RONY LUONG/NYT Itâs been a long, strange trip in the four decades since Rick Doblin, a pioneering psychedelics researcher, dropped his first hit of acid in college and decided to dedicate his life to the healing powers of mind-altering compounds. Even as anti-drug campaigns led to the criminalization of Ecstasy, LSD and magic mushrooms, and drove most researchers from the field, Doblin continued his quixotic crusade with financial help from his parents.
The Psychedelic Revolution Is Coming. Psychiatry May Never Be the Same. yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
MDMA, magic mushrooms could be the hottest entry in psychiatry, researchers hopeful Psychedelics could be the newest entry to psychiatric therapies as researchers exploring the therapeutic prowess of the compounds are optimistic about its impact in treating post-traumatic stress disorder. advertisement Image for Representation. (Photo: Reuters) Rick Doblin, founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS), is exploring the healing power of compounds such as LSD, Ecstasy and magic mushrooms in treating mental health disorders in patients, amid anti-drug campaigns that criminalise the use of such substances. The first Phase 3 clinical trial of Doblin s study conducted with psychedelic-assisted therapy, found that MDMA paired with counseling brought substantial relief to patients with severe post-traumatic stress disorder, the New York Times reported. Nature Medicine is also expected to publish results of his lab study on MDMA soon - which could be a major push for Doblin in his fight for mainstream acceptance of psychedelics.